TuHURA Biosciences Inc Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline AGNC Q1 2026 Earnings EPS Beats Estimates by 145 Amid Stock Decline HCAT Q1 2026 Earnings EPS Surpasses Estimates on Improved Operations ARQT Q1 2026 Earnings EPS Miss Amid Biotech Sector Headwinds CREG Q1 2026 Earnings Loss per Share of 003 as Company Continues Strategic Transition Ohio Valley Banc Corp OVBC Q3 2025 Earnings Solid EPS Performance Drives Modest Stock Gain